Work

Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia

Year: 2013

Type: article

Study design: Observational Study

Source: Neuropsychopharmacology

DOI: 10.1038/npp.2013.94

Authors: Masashi Ikeda, Yuko Okahisa, Branko Aleksic, Mujun Won, Naoki Kondo, Nobuya Naruse, Kumi Aoyama-Uehara, Ichiro Sora, Masaomi Iyo, Ryota Hashimoto, Yoshiya Kawamura, Nao Nishida, Taku Miyagawa, Masatoshi Takeda, Tsukasa Sasaki, Katsushi Tokunaga, Norio Ozaki, Hiroshi Ujike, Nakao Iwata

Institutions: Fujita Health University, Okayama University, Nagoya University, Koujin Hospital, Saitama Psychiatric Medical Center, Kasugai Municipal Hospital, Tohoku University, Chiba University, Kanazawa University, Hamamatsu University School of Medicine, Molecular Research Center for Children's Mental Development, The University of Osaka, The University of Tokyo

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Novartis Foundation, Ministry of Education, Culture, Sports, Science and Technology, SENSHIN Medical Research Foundation, Japan Society for the Promotion of Science, Core Research for Evolutional Science and Technology

Awards: Detecting genetic component of schizophrenia, Searching for susceptibility genes in narcolepsy, and the therapeutic application, Identification of rare risk variants for schizophrenia using target resequencing, Generation of biological models with AD / HD patients induced iPS cells, Platform of large scale and high quality genomics and bioinformatics: Towards the advancement of genome sciences in academia

OpenAlex ID: W2084843232

FWCI: 2.976

Cites: 28

Cited by: 64

Related to: 10